Androgen Deprivation Therapy–Induced Cardiovascular Disease
نویسنده
چکیده
Why did the patients who underwent orchidectomy have statistically significantly higher prostatespecific antigen? It would have been informative if we had the baseline glucose, lipid profile, and indices of obesity for patients receiving ADT to show that their cardiovascular risk factors definitely increased with ADT. As there is a definite increase in cardiovascular risk factors with ADT, we should advise lifestyle modifications and/or lipid-lowering agents before initiating therapy.
منابع مشابه
From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination.
References 1. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection. The effect of study arm on prostate cancer treatment in the large screening trial ERSPC. Impact of androgen deprivation therapy on cardiovascu...
متن کاملCardiovascular risks of androgen deprivation therapy.
Prostate adenocarcinoma is the most common cancer type in the male sex after skin cancer. Among the several types of treatment for prostate cancer, the androgen deprivation therapy has been highly recommended in patients with metastatic or locally advanced disease, which probably results in increased survival. However, the androgen deprivation is the cause of several adverse effects. Complicati...
متن کاملReduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation
Objectives. To investigate if androgen deprivation therapy exposure is associated with additional risk factors for cardiovascular disease and metabolic treatment-related toxicities. Methods. One hundred and seven men (42-89 years) with prostate cancer undergoing androgen deprivation therapy completed a maximal graded objective exercise test to determine maximal oxygen uptake, assessments for re...
متن کاملAdverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications.
Prostate cancer is the most common cancer among men and androgen deprivation therapy (ADT) is the most effective treatment for this disease. The cornerstone of the treatment of prostate cancer is inhibition of testosterone production which interrupts testosterone-induced growth of the prostate tumor. The dramatic decrease in testosterone levels, however, has several undesirable effects on the m...
متن کاملAndrogen deprivation therapy and cardiovascular disease: what is the linking mechanism?
The past decade has brought increased awareness of the potential adverse effects of androgen deprivation therapy (ADT) in men with prostate cancer. Arguably the most important and controversial of these is the increased risk of cardiovascular morbidity and mortality. Although multiple observational studies have shown that men treated with ADT are at increased risk of developing atherosclerotic ...
متن کاملCardiovascular risk associated with androgen deprivation therapy.
Prostate cancer is the second leading cause of cancer-related death among men in the United States.[1] Androgen deprivation therapy (ADT) is a common treatment for prostate cancer. ADT includes gonadotropin-releasing hormone (GnRH) agonists (leuprolide, goserelin, triptorelin), bilateral orchiectomy, and anti-androgen receptor blockers such as flutamide and bicalutamide. Several studies have no...
متن کامل